spacer
home > epc > autumn 2005 > opportunities in the chinese pharmaceutical market
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

Social Media in Pharmaceuticals

9-10 July 2012, London, UK

2012 is an exciting year for social media: the year social media goes viral. The pharmaceutical industry have been waiting for guidance from the FDA and now they have finally shed some light with their 'Off-Label Use' with some mention regarding social media. Although this is not directly aimed at social media, the fact that the FDA discusses social media demonstrates the importance.
More info >>

 
News and Press Releases

Norwich Pharmaceuticals Announces Significant Business Growth

Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, announced today that the company has achieved significant business growth in first quarter, 2012 as compared to the same period in 2011. Key growth areas include volume of projects currently in development and commercial production, scope of projects expanded into multiple service categories, and total value of new business won.
More info >>

 
Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.